DHG Pharmaceutical JSC (HOSE: DHG)

Market Cap	14.40T
Revenue (ttm)	4.96T
Net Income (ttm)	804.09B
Shares Out	130.75M
EPS (ttm)	6,149.98
PE Ratio	17.90
Forward PE	14.32
Dividend	7,500.00 (6.81%)
Ex-Dividend Date	Dec 24, 2024

Volume	29,700
Open	110,900
Previous Close	110,900
Day's Range	109,500 - 111,400
52-Week Range	98,400 - 125,900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 20, 2025

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products primarily in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in health supplements and pharmaceuticals cosmeceuticals. It also exports its products to Moldova, Ukraine, Romania, Myanmar, Russi...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,789
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2023, DHG Pharmaceutical JSC's revenue was 5.02 trillion, an increase of 7.26% compared to the previous year's 4.68 trillion. Earnings were 1.02 trillion, an increase of 6.31%.